– Neuroendocrine Prostate Cancer is Growing Unmet Medical Need – NEW YORK, Aug. 24, 2022 (GLOBE…
CORAL GABLES, Fla., Aug. 24, 2022 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX), a…
Virtual event on Wednesday, September 7 at 4:30 PM ET will feature key opinion leader…
• The National Screening Laboratory of Sanquin Blood Supply Foundation joins MosaiQ Innovator’s Circle JERSEY,…
Sepsis Phase II protocol amendments have been cleared by regulatory authorities in Israel, Spain, and…
VANCOUVER, British Columbia, Aug. 24, 2022 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the…
Pegcetacoplan treatment effect accelerated between months 18-24, demonstrating a robust reduction of GA lesion growth…
NEW YORK, Aug. 24, 2022 (GLOBE NEWSWIRE) — Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical…
33% improved by one fibrosis stage without worsening of NASH; 25% of patients treated with…
Oral presentation will feature results from Part A of the Phase 2/3 RINGSIDE clinical study…
– Renowned virologist, Nobel laureate and Assembly Bio board member, Sir Michael Houghton, PhD, will…
NEWARK, Calif., Aug. 24, 2022 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage…
Patient relationship management and contact center technology enables Science 37 to achieve significantly greater patient…
WALTHAM, Mass., Aug. 24, 2022 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a leading innovator of…
Results indicate significant decrease in cocaine craving in a sub-group that received the treatment TEL…
CAMBRIDGE, Mass., Aug. 24, 2022 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader…
Presentation will highlight opportunity for oral difelikefalin to address a significant unmet need in the…
SUNNYVALE, Calif., Aug. 24, 2022 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], today announced that it…
BASKING RIDGE, N.J., Aug. 24, 2022 (GLOBE NEWSWIRE) — All customers with a 484 or…
KeyedIn Enterprise 7.5 Supports PMOs with the Only PPM Software on the Market to Offer…